Cyclical regulation of GnRH gene expression in GT1-7 GnRH-secreting neurons by melatonin - PubMed

Cyclical regulation of GnRH gene expression in GT1-7 GnRH-secreting neurons by melatonin

D Roy et al. Endocrinology. 2001 Nov.

Abstract

The pineal hormone melatonin plays an important role in the neuroendocrine control of reproductive physiology, but its effects on hypothalamic GnRH neurons are not yet known. We have found that GT1-7 GnRH-secreting neurons express membrane-bound G protein-coupled melatonin receptors, mt1 (Mel-1a) and MT2 (Mel-1b) as well as the orphan nuclear receptors ROR alpha and RZR beta. Melatonin (1 nM) significantly downregulates GnRH mRNA levels in a 24-h cyclical manner, an effect that is specifically inhibited by the melatonin receptor antagonist luzindole (10 microM). Repression of GnRH gene expression by melatonin appears to occur at the transcriptional level and can be mapped to the GnRH neuron-specific enhancer located within the 5' regulatory region of the GnRH gene. Using transient transfection of GT1-7 cells, downregulation of GnRH gene expression by melatonin was further localized to five specific regions within the GnRH enhancer including -1827/-1819, -1780/-1772, -1746/-1738, -1736/-1728, and -1697/-1689. Interestingly, the region located at -1736/-1728 includes sequences that correspond to two direct repeats of hexameric consensus binding sites for members of the ROR/RZR orphan nuclear receptor family. To begin to dissect the mechanisms involved in the 24-h cyclical regulation of GnRH transcription, we have found that melatonin (10 nM) induces rapid internalization of membrane-bound mt1 receptors through a beta-arrestin 1-mediated mechanism. These results provide the first evidence that melatonin may mediate its neuroendocrine control on reproductive physiology through direct actions on the GnRH neurons of the hypothalamus, both at the level of GnRH gene expression and through the regulation of G protein-coupled melatonin receptors.

Similar articles

• Repression of gonadotropin-releasing hormone (GnRH) gene expression by melatonin may involve transcription factors COUP-TFI and C/EBP beta binding at the GnRH enhancer.

  Gillespie JM, Roy D, Cui H, Belsham DD. Gillespie JM, et al. Neuroendocrinology. 2004 Feb;79(2):63-72. doi: 10.1159/000076629. Neuroendocrinology. 2004. PMID: 15004428

• Cetrorelix, a gonadotropin-releasing hormone antagonist, induces the expression of melatonin receptor 1a in the gonadotropin-releasing hormone neuronal cell line GT1-7.

  Ishii H, Sato S, Yin C, Sakuma Y, Kato M. Ishii H, et al. Neuroendocrinology. 2009;90(3):251-9. doi: 10.1159/000231993. Epub 2009 Jul 30. Neuroendocrinology. 2009. PMID: 19641296

• Mammalian melatonin receptors: molecular biology and signal transduction.

  von Gall C, Stehle JH, Weaver DR. von Gall C, et al. Cell Tissue Res. 2002 Jul;309(1):151-62. doi: 10.1007/s00441-002-0581-4. Epub 2002 May 18. Cell Tissue Res. 2002. PMID: 12111545 Review.

• The orphan receptor family RZR/ROR, melatonin and 5-lipoxygenase: an unexpected relationship.

  Carlberg C, Wiesenberg I. Carlberg C, et al. J Pineal Res. 1995 May;18(4):171-8. doi: 10.1111/j.1600-079x.1995.tb00157.x. J Pineal Res. 1995. PMID: 8531047 Review.

Cited by

• The melatonergic system in mood and anxiety disorders and the role of agomelatine: implications for clinical practice.

  De Berardis D, Marini S, Fornaro M, Srinivasan V, Iasevoli F, Tomasetti C, Valchera A, Perna G, Quera-Salva MA, Martinotti G, di Giannantonio M. De Berardis D, et al. Int J Mol Sci. 2013 Jun 13;14(6):12458-83. doi: 10.3390/ijms140612458. Int J Mol Sci. 2013. PMID: 23765220 Free PMC article. Review.

• International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors.

  Dubocovich ML, Delagrange P, Krause DN, Sugden D, Cardinali DP, Olcese J. Dubocovich ML, et al. Pharmacol Rev. 2010 Sep;62(3):343-80. doi: 10.1124/pr.110.002832. Epub 2010 Jul 6. Pharmacol Rev. 2010. PMID: 20605968 Free PMC article.

• Melatonin as an Anti-Inflammatory Agent Modulating Inflammasome Activation.

  Favero G, Franceschetti L, Bonomini F, Rodella LF, Rezzani R. Favero G, et al. Int J Endocrinol. 2017;2017:1835195. doi: 10.1155/2017/1835195. Epub 2017 Oct 1. Int J Endocrinol. 2017. PMID: 29104591 Free PMC article. Review.

• Functional MT1 and MT2 melatonin receptors in mammals.

  Dubocovich ML, Markowska M. Dubocovich ML, et al. Endocrine. 2005 Jul;27(2):101-10. doi: 10.1385/ENDO:27:2:101. Endocrine. 2005. PMID: 16217123 Review.

• Orofacial inflammatory pain affects the expression of MT1 and NADPH-d in rat caudal spinal trigeminal nucleus and trigeminal ganglion.

  Huang F, He H, Fan W, Liu Y, Zhou H, Cheng B. Huang F, et al. Neural Regen Res. 2013 Nov 15;8(32):2991-3002. doi: 10.3969/j.issn.1673-5374.2013.32.002. Neural Regen Res. 2013. PMID: 25206619 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Silverchair Information Systems